Alnylam Pharmaceuticals Aktie
228,50
EUR
+0,20
EUR
+0,09
%
244,41
USD
-1,10
USD
-0,45
%
Alnylam Pharmaceuticals Aktie Analyse
| 01.10.18 | Alnylam Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 13.08.18 | Alnylam Pharmaceuticals Buy | Stifel, Nicolaus & Co., Inc. | |
| 07.08.18 | Alnylam Pharmaceuticals Buy | Stifel, Nicolaus & Co., Inc. | |
| 05.07.18 | Alnylam Pharmaceuticals Buy | Chardan Capital Markets | |
| 04.05.18 | Alnylam Pharmaceuticals Hold | Stifel, Nicolaus & Co., Inc. | |
| 16.02.18 | Alnylam Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 08.01.18 | Alnylam Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 08.11.17 | Alnylam Pharmaceuticals overweight | Barclays Capital | |
|
Werbung
|
|||
| 08.11.17 | Alnylam Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 03.11.17 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 02.11.17 | Alnylam Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 30.10.17 | Alnylam Pharmaceuticals Buy | FBR & Co. | |
| 21.09.17 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 15.05.17 | Alnylam Pharmaceuticals Buy | Chardan Capital Markets | |
| 21.04.17 | Alnylam Pharmaceuticals Outperform | BMO Capital Markets | |
| 09.02.17 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 19.12.16 | Alnylam Pharmaceuticals Buy | Chardan Capital Markets | |
| 30.11.16 | Alnylam Pharmaceuticals Buy | Chardan Capital Markets | |
| 16.11.16 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 06.10.16 | Alnylam Pharmaceuticals Outperform | FBR & Co. | |
| 06.10.16 | Alnylam Pharmaceuticals Hold | Stifel, Nicolaus & Co., Inc. | |
| 06.10.16 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 06.10.16 | Alnylam Pharmaceuticals Buy | Chardan Capital Markets | |
| 26.05.16 | Alnylam Pharmaceuticals Buy | Chardan Capital Markets | |
| 05.04.16 | Alnylam Pharmaceuticals Buy | Chardan Capital Markets | |
| 11.08.15 | Alnylam Pharmaceuticals Outperform | FBR Capital | |
| 22.04.15 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 04.03.15 | Alnylam Pharmaceuticals overweight | Barclays Capital | |
| 17.11.14 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 13.11.09 | Alnylam Pharmaceuticals outperform | Rodman & Renshaw, LLC | |
| 10.06.09 | Alnylam Pharmaceuticals buy | Jefferies & Company Inc. | |
| 10.06.09 | Alnylam Pharmaceuticals buy | ROTH Capital Partners, LLC | |
| 21.01.09 | Alnylam Pharmaceuticals market outperform | Rodman & Renshaw, LLC | |
| 11.12.08 | Alnylam Pharmaceuticals | Focus Money | |
| 19.02.08 | Alnylam Pharmaceuticals | Biotech-Report | |
| 24.10.07 | Alnylam Pharmaceuticals market outperform | Rodman & Renshaw | |
| 10.07.07 | Alnylam Pharmaceuticals market outperform | Rodman & Renshaw | |
| 10.07.07 | Alnylam Pharmaceuticals above average | Caris & Company | |
| 12.05.06 | Alnylam Pharmaceuticals Above Average | Caris & Company | |
| 13.02.06 | Alnylam Pharmaceuticals Buy | Needham & Co | |
| 13.02.06 | Alnylam Pharmaceuticals Buy | Needham & Co | |
| 16.12.05 | Alnylam Pharmaceuticals Buy | Banc of America Sec. | |
| 02.02.05 | Alnylam Pharmaceuticals Buy | Banc of America Sec. | |